The S&P 500 Index ($SPX) (SPY) today is up +0.29%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.12%, and the Nasdaq ...

HII's Q4 revenues total $3 billion, which miss the Zacks Consensus Estimate by 0.9%. The top line declines 5.4% year over ...

Reports Q4 revenue $829.4M, consensus $827.43M. CEO Ivo Jurek commented, “In 2024, we generated a 180 basis point increase in our gross margin ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on ...

ConocoPhillips (NYSE: COP) reported Q4 results, with $14.74B revenue and $1.98 EPS, surpassing expectations. Company also announced dividends and production targets for 2025.

Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted ...

Eli Lilly's Q4 revenue surged 45% to $13.53 billion, fueled by Mounjaro and Zepbound. 2025 guidance forecasts up to $61 billion in sales, driven by new drug launches.

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Shares of FMC Corp. lost roughly a third of their value Wednesday, making the stock by far the biggest decliner in the S&P 500 after it reported a net loss for the fourth quarter.

Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...

Media company The New York Times (NYSE:NYT) reported mixed results on Wednesday, Feb. 5, in its fourth-quarter earnings ...